What is hyperreflexia, its causes, clinical significance, and recommended evaluation and management?

Hyperreflexia: Definition and Clinical Context

Hyperreflexia refers to exaggerated deep tendon reflexes that indicate upper motor neuron dysfunction, most commonly seen in conditions affecting the corticospinal tract such as spinal cord injury, amyotrophic lateral sclerosis (ALS), or stroke.

What Hyperreflexia Represents

Hyperreflexia is a pathological increase in reflex responses caused by loss of descending inhibitory control from the brain over spinal reflex arcs. When upper motor neurons are damaged, the normal suppression of spinal reflexes is lost, resulting in brisk or exaggerated responses to tendon stretch 1.

Key Pathophysiological Mechanisms

The underlying mechanisms include:

• Loss of supraspinal inhibition: Damage to descending corticospinal pathways removes the brain's regulatory control over spinal reflexes
• Proprioceptive afferent circuit changes: Following corticospinal tract injury, 1A fiber sprouting enhances reflex signaling, while reduced GABAergic presynaptic inhibition fails to compensate in affected regions 2
• Preserved spinal reflex arcs: The reflex pathway itself (sensory nerve → spinal cord → motor nerve) remains intact despite upper motor neuron damage

Clinical Significance and Associated Conditions

Upper Motor Neuron Diseases

Hyperreflexia with hypertonicity indicates upper motor neuron degeneration, as seen in:

• Amyotrophic lateral sclerosis (ALS): Patients present with both hypertonicity and hyperreflexia (upper motor neuron signs) alongside muscle fasciculations, weakness, and atrophy (lower motor neuron signs) 1
• Spinal cord injury: Lesions above T6 commonly produce hyperreflexia below the injury level
• Stroke or brain lesions: Corticospinal tract damage from any cause

Important Clinical Caveat

In atypical presentations, particularly pure motor variants with acute motor axonal neuropathy (AMAN) subtype, normal or even exaggerated reflexes may be observed despite peripheral nerve pathology 3. This occurs in some Guillain-Barré syndrome variants and should not automatically be interpreted as upper motor neuron disease.

Distinguishing Hyperreflexia from Autonomic Hyperreflexia

Critical Distinction

Do not confuse hyperreflexia (exaggerated tendon reflexes) with autonomic hyperreflexia (also called autonomic dysreflexia), which is a distinct and potentially life-threatening syndrome:

• Autonomic hyperreflexia occurs in 80-85% of patients with spinal cord injuries at or above T6 4, 5, 6
• It represents excessive uncontrolled sympathetic output triggered by noxious stimuli below the injury level
• Clinical features include paroxysmal hypertension, bradycardia, headache, diaphoresis, and flushing 5, 6
• Most commonly triggered by bladder or bowel distention 6, 7
• Requires immediate intervention: remove the offending stimulus and consider direct vasodilators (nifedipine, nitroprusside) for acute episodes 7, 8

Clinical Evaluation Approach

Physical Examination Findings

Look for these specific features:

• Brisk or exaggerated deep tendon reflexes (3+ to 4+ on standard scale)
• Clonus: Sustained rhythmic muscle contractions with maintained stretch
• Positive Babinski sign: Upgoing great toe with fanning of other toes
• Increased muscle tone (spasticity)
• Absence of muscle atrophy (distinguishes from lower motor neuron disease)

Pattern Recognition

• Bilateral hyperreflexia: Suggests bilateral corticospinal tract involvement (cervical myelopathy, ALS, cerebral palsy)
• Unilateral hyperreflexia: Indicates contralateral brain or spinal cord lesion (stroke, hemisection)
• Hyperreflexia with absent reflexes elsewhere: Consider combined upper and lower motor neuron disease (ALS) 1

Diagnostic Workup

For suspected upper motor neuron disease:

• MRI of brain and/or spine without contrast: Optimal imaging for corticospinal tract pathology 1
• Electromyography and nerve conduction studies: Essential for diagnosing ALS and distinguishing upper from lower motor neuron disease 1
• CT has limited utility due to poor soft-tissue characterization compared to MRI 1

Management Considerations

Addressing the Underlying Cause

Management depends entirely on the etiology:

• Spinal cord injury: Focus on preventing autonomic dysreflexia complications and managing spasticity
• ALS: Supportive care with median survival of 3-4 years after symptom onset 1
• Acute inflammatory conditions: Consider immunotherapy (IVIG 0.4 g/kg daily for 5 days or plasma exchange) if Guillain-Barré syndrome is diagnosed 3

Spasticity Management

When hyperreflexia causes problematic spasticity:

• Antispasmodic medications (baclofen, tizanidine)
• Physical therapy and stretching programs
• Botulinum toxin injections for focal spasticity
• Intrathecal baclofen pump for severe cases

Perioperative Awareness

For patients with spinal cord injury above T6, anesthesiologists must anticipate autonomic hyperreflexia during surgery 4. Spinal or epidural anesthesia is preferred to prevent hypertensive crises triggered by surgical stimulation 8.